不同控制水平哮喘儿童的肠道菌群分析
Structure analysis of the gut microbiota in asthmatic children with different control levels
Received date: 2021-10-29
Online published: 2022-05-13
目的 观察不同控制水平哮喘患儿肠道菌群的差异。方法 选取2020年1月—2020年12月就诊的10~12岁哮喘儿童,依据哮喘控制水平分级标准分为控制组与未控制/部分控制组,同时将同期健康体检儿童作为对照组,留取新鲜粪便样本进行肠道菌群16S rRNA的检测。结果 共纳入哮喘患儿30例。控制组16例,男10例、女6例,年龄(12.19±1.11)岁;未控制/部分控制组14例,男8例、女6例,年龄(12.92±1.59)岁;对照组12例,男6例、女6例,年龄(13.17±1.03)岁。三组间性别、年龄差异均无统计学意义(P>0.05)。控制组治疗时间为(1.22±0.18)年,未控制/部分控制组为(1.24±0.15)年,差异无统计学意义(P>0.05)。三组间FEF50绝对值差异有统计学意义(P<0.05)。三组之间Alpha多样性指数(4个指数)差异均无统计学意义(P>0.05)。未控制/部分控制组中韦荣球菌属(Veillonella)物种相对丰度为0.06(0.01~0.25)%,控制组为0.53(0.19~0.92)%,对照组为0.17(0.09~0.82)%,三组间差异有统计学意义(P<0.05)。两两比较发现,未控制/部分控制组中Veillonella丰度较控制组以及对照组明显降低,差异有统计学意义(P<0.05)。行ROC曲线分析可见,Veillonella丰度对哮喘控制水平预测的曲线下面积为0.82(95%CI:0.66~0.98)。结论 控制不佳的哮喘患儿肠道菌群中Veillonella丰度明显减少,对哮喘控制水平评估以及辅助治疗可能具有一定的指导意义。
邹羽彤 , 黄林生 , 钟慧 , 杨蓉 , 谷丽 . 不同控制水平哮喘儿童的肠道菌群分析[J]. 临床儿科杂志, 2022 , 40(5) : 382 -387 . DOI: 10.12372/jcp.2022.21e1496
Objectives To observe the difference of gut microbiota in children with asthma at different control levels. Methods Thirty children aged 10 to 12 with asthma were selected from January 2020 to December 2020 and divided into well-controlled group (16 patients) and non-control / partial control group (14 patients) according to the grading standard of asthma control level. Twelve healthy children were selected as the control group. Fresh fecal samples were collected from three group for the detection of 16S rRNA of gut microbiota. Results A total of 30 children with asthma were included. There were 16 cases in the well-controlled group, 10 males and 6 females, aged (12.19±1.11) years; 14 cases in the uncontrolled/partially controlled group, 8 males and 6 females, aged (12.92±1.59) years; and 12 cases in the control group, 6 males and 6 females, aged (13.17±1.03) years. The differences in gender and age among the three groups were not statistically significant (P>0.05). The duration of treatment was (1.22±0.18) years in the well-controlled group and (1.24±0.15) years in the uncontrolled/partially controlled group, with no statistically significant differences (P>0.05). The difference in the absolute value of FEF50 among the three groups was statistically significant (P<0.05). The differences in Alpha diversity index (4 indices) among the three groups were not statistically significant (P>0.05). The relative abundance of Veillonella species in the uncontrolled/partially controlled group was 0.06 (0.01-0.25)%, 0.53 (0.19-0.92)% in the well-controlled group and 0.17 (0.09-0.82)% in the control group, with statistically significant differences among the three groups (P<0.05). A two-by-two comparison revealed that the abundance of Veillonella was significantly lower in the uncontrolled/partially controlled group compared to the well-controlled group as well as the control group, and the difference was statistically significant (P<0.05). ROC curve analysis showed that the area under the curve for the prediction of Veillonella abundance on the level of asthma control was 0.82 (95% CI: 0.66 to 0.98). Conclusions The abundance of Veillonella in the intestinal flora of poorly controlled asthmatic children was significantly reduced, which may be a guideline for the assessment of asthma control level as well as adjuvant therapy.
Key words: asthma; control level; Veillonella; gut microbiota; child
[1] | 全国儿科哮喘协作组. 全国90万0-14岁儿童中支气管哮喘患病情况调查[J]. 中华结核病科杂志, 1993, 16(Z1): 64-68. |
[2] | 刘传合, 洪建国, 尚云晓, 等. 第三次中国城市儿童哮喘流行病学调查[J]. 中华儿科杂志, 2013, 51(10): 729-735. |
[3] | 全国儿科哮喘防治协作组. 中国城区儿童哮喘患病率调查[J]. 中华儿科杂志, 2003, 41(2): 123-127. |
[4] | Xiang L, Zhao J, Zheng YJ, et al. Uncontrolled and its asthma risk factors in Chinese children: A cross-sectional observational study[J]. J Asthma, 2016, 53(7): 699-706. |
[5] | Loftus PA, Wise SK. Epidemiology of asthma[J]. Curr Opin Otolaryngol Head Neck Surg, 2016, 24(3): 245-249. |
[6] | McAleer JP, Kolls JK. Contributions of the intestinal microbiome in lung immunity[J]. Eur J Immunol, 2018, 48(1): 39-49. |
[7] | 娄俊丽, 黄永坤. 过敏性疾病与肠道菌群[J]. 临床儿科杂志, 2009, 2(27): 196-198. |
[8] | Stokholm J, Blaser MJ, Thorsen J, et al. Maturation of the gut microbiome and risk of asthma in childhood[J]. Nat commun, 2018, 9(1): 141. |
[9] | Arrieta MC, Stiemsma LT, Dimitriu PA, et al. Early infancy microbial and metabolic alterations affect risk of childhood asthma[J]. Sci Transl Med, 2015, 7(307):307ra152. |
[10] | Abrahamsson TR, Jakobsson HE, Andersson AF, et al. Low gut microbiota diversity in early infancy precedes asthma at school age[J]. Clin Exp Allergy, 2014, 44(6): 842-850. |
[11] | 中华医学会呼吸病学分会哮喘学组. 支气管哮喘防治指南(2016年版)[J]. 中华结核和呼吸杂志, 2016, 39(9): 675-697. |
[12] | 洪建国, 鲍一笑. 重视儿童支气管哮喘的规范化诊治[J]. 中华儿科杂志, 2016, 54(3): 161-162. |
[13] | 乔廉洁, 薄建萍. 哮喘患者小气道功能与气道高反应性的关系探讨[J]. 临床肺科杂志, 2019, 24(9): 1622-1626. |
[14] | Huang J, Zhang M, Zhang X, et al. Airway hyper-responsiveness and small airway function in children with well-controlled asthma[J]. Pediatr Res, 2015, 77(6): 819-822. |
[15] | van der Wiel E, ten Hacken NH, Postma DS, et al. Small-airways dysfunction associates with respiratory symptoms and clinical features of asthma: a systematic review[J]. Allergy Clin lmmunol, 2013, 131(3): 646-657. |
[16] | Cottini M, Lombardi C, Micheletto C. Small airway dysfunction and bronchial asthma control: the state of the art[J]. Asthma Res Pract, 2015, 1: 1-13. |
[17] | 宋荟琴, 路海荣. 哮喘患儿血清维生素 D水平与哮喘控制、肺功能及免疫功能的相关性研究[J]. 检验医学与临床, 2019, 16(16): 2335-2338. |
[18] | 王亚娟, 付三仙, 张贝贝, 等. 肠道微生物与过敏性疾病关系的研究进展[J]. 中国免疫学杂志, 2018, 34(5): 786-789. |
[19] | Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system[J]. Science, 2012, 336(6086): 1268-1273. |
[20] | 何学佳, 朱薇薇, 毕玫荣. 肠道菌群通过短链脂肪酸参与过敏性哮喘气道高反应机制研究进展[J]. 中国儿童保健杂志, 2020, 28(4): 431-434. |
[21] | Hevia A, Milani C, Lopez P, et al. Allergic patients with long-term asthma display low levels of Bifidobacterium adolescentis[J]. PloS one, 2016, 11(2): e0147809. |
[22] | Frati F, Salvatori C, Incorvaia C, et al. The role of the microbiome in asthma: The gut-lung axis[J]. Int J Mol Sci, 2018, 20(1): 123. |
[23] | Roduit C, Frei R, Ferstl R, et al. High levels of butyrate and propionate in early life are associated with protection against atopy[J]. Allergy, 2019, 74(4): 799-809. |
[24] | Kozik AJ, Huang YJ. The microbiome in asthma: Role in pathogenesis, phenotype, and response to treatment[J]. Ann Allergy Asthma Immunol, 2019, 122(3): 270-275. |
[25] | Dang AT, Marsland BJ. Microbes, metabolites, and the gut-lung axis[J]. Mucosal immunology, 2019, 12(4): 843-850. |
[26] | 任盛, 夏梅梅, 赵将, 等. 肠道益生菌辅治对支气管哮喘患儿免疫功能、肠道菌群及复发率的影响[J]. 中国全科医学, 2020, 23(S1): 72-75. |
[27] | Du XZ, Wand LY, WU SY, et al. Efficacy of probiotic supplementary therapy for asthma, allergic rhinitis, and wheeze: a meta-analysis of randomized controlled trials[J]. Allergy Asthma Proc, 2019, 40(4): 250-260. |
[28] | Giudice MMD, Indolfi C, Capsso M, et al. Bifidobacterium mixture (B longum BB536, B infantis M-63, B breve M-16V) treatment in children with seasonal allergic rhinitis and intermittent asthma[J]. Ital J Pediatr, 2017, 43(1): 25. |
[29] | Huang CF, Chie WC, Wang IJ. Efficacy of Lactobacillus administration in school age children with asthma: a randomized, placebo-controlled trial[J]. Nutrients, 2018, 10(11): 1678. |
[30] | Hufnagl K, Pali-Scholl I, Roth-Walter F, et al. Dysbiosis of the gut and lung microbiome has a role in asthma[J]. Semin Immunopathol, 2020, 42(1): 75-93. |
/
〈 |
|
〉 |